• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单次口服头孢泊肟酯后血浆和胸腔积液中头孢泊肟的浓度。

Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.

作者信息

Dumont R, Guetat F, Andrews J M, Sultan E, Lenfant B

机构信息

Department of Pneumology, Regional Hospital Centre, Bourg en Bresse, France.

出版信息

J Antimicrob Chemother. 1990 Dec;26 Suppl E:41-6. doi: 10.1093/jac/26.suppl_e.41.

DOI:10.1093/jac/26.suppl_e.41
PMID:2292529
Abstract

Eighteen patients of either sex with pleural effusions underwent aspiration 3, 6 or 12 h after receiving a single oral dose of cefpodoxime proxetil equivalent to 200 mg cefpodoxime. The mean concentrations of cefpodoxime in pleural fluid were, respectively, 0.62, 1.84 and 0.78 mg/l for these three time intervals, the corresponding ratios between pleural fluid and plasma concentrations being 0.24, 0.67 and 1.07. The findings indicate that there is good penetration of cefpodoxime into pleural fluid. Concentrations between 3 and 12 h after dosing were equal to or above the MIC90 for most of the organisms commonly found in lower respiratory tract infections.

摘要

18例有胸腔积液的患者,无论男女,在单次口服相当于200mg头孢泊肟的头孢泊肟酯后3、6或12小时接受胸腔穿刺。在这三个时间间隔内,胸腔积液中头孢泊肟的平均浓度分别为0.62、1.84和0.78mg/L,胸腔积液与血浆浓度的相应比值分别为0.24、0.67和1.07。这些结果表明头孢泊肟能很好地渗透到胸腔积液中。给药后3至12小时的浓度等于或高于下呼吸道感染中常见的大多数病原体的MIC90。

相似文献

1
Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.单次口服头孢泊肟酯后血浆和胸腔积液中头孢泊肟的浓度。
J Antimicrob Chemother. 1990 Dec;26 Suppl E:41-6. doi: 10.1093/jac/26.suppl_e.41.
2
Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.单次口服头孢泊肟酯后血浆和扁桃体组织中头孢泊肟的浓度。
J Antimicrob Chemother. 1990 Dec;26 Suppl E:47-51. doi: 10.1093/jac/26.suppl_e.47.
3
Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil.单次口服头孢泊肟酯后血浆及肺组织中头孢泊肟的浓度。
J Antimicrob Chemother. 1990 Dec;26 Suppl E:35-40. doi: 10.1093/jac/26.suppl_e.35.
4
Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.口服头孢泊肟酯后头孢泊肟在血浆和皮肤水疱液中的药代动力学。
Antimicrob Agents Chemother. 1990 Jun;34(6):1094-9. doi: 10.1128/AAC.34.6.1094.
5
Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.头孢泊肟酯在未感染患者肺实质和上皮衬液中的渗透情况。
Antimicrob Agents Chemother. 1992 Oct;36(10):2099-103. doi: 10.1128/AAC.36.10.2099.
6
Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.头孢泊肟在年轻和老年志愿者单次给药后的药代动力学
J Antimicrob Chemother. 1990 Dec;26 Suppl E:21-8. doi: 10.1093/jac/26.suppl_e.21.
7
Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.头孢泊肟酯单剂量及多剂量口服给药后头孢泊肟的药代动力学和耐受性研究。
J Clin Pharmacol. 1991 Dec;31(12):1137-45. doi: 10.1002/j.1552-4604.1991.tb03686.x.
8
Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.血清和支气管黏膜活检组织中头孢泊肟的浓度。
J Antimicrob Chemother. 1992 Jul;30(1):67-71. doi: 10.1093/jac/30.1.67.
9
Cefpodoxime proxetil concentrations in head and neck tissues.头孢泊肟酯在头颈部组织中的浓度。
Infection. 1991 Jan-Feb;19(1):41-3. doi: 10.1007/BF01643757.
10
Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.头孢泊肟酯与乙酰半胱氨酸联合给药时的生物利用度。
Arzneimittelforschung. 1996 Apr;46(4):435-8.

引用本文的文献

1
Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.头孢泊肟酯:儿科患者细菌感染治疗应用综述
Paediatr Drugs. 2001;3(2):137-58. doi: 10.2165/00128072-200103020-00006.
2
Clinical pharmacokinetics of newer cephalosporins.新型头孢菌素的临床药代动力学
Clin Pharmacokinet. 1995 May;28(5):361-84. doi: 10.2165/00003088-199528050-00003.
3
Cefpodoxime proxetil in the treatment of lower respiratory tract infections.头孢泊肟酯治疗下呼吸道感染
Drugs. 1991;42 Suppl 3:34-40. doi: 10.2165/00003495-199100423-00008.
4
Cefpodoxime proxetil in upper respiratory tract infections.头孢泊肟酯在上呼吸道感染中的应用
Drugs. 1991;42 Suppl 3:25-33. doi: 10.2165/00003495-199100423-00007.
5
A review of the pharmacokinetics of cefpodoxime proxetil.头孢泊肟酯的药代动力学综述。
Drugs. 1991;42 Suppl 3:13-21. doi: 10.2165/00003495-199100423-00005.
6
Comparative study of penetration of lomefloxacin and ceftriaxone into transudative and exudative pleural effusion.洛美沙星与头孢曲松在漏出液和渗出液中渗透情况的对比研究。
Antimicrob Agents Chemother. 1992 Dec;36(12):2774-7. doi: 10.1128/AAC.36.12.2774.
7
Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.头孢泊肟酯。对其抗菌活性、药代动力学特性及治疗潜力的综述。
Drugs. 1992 Nov;44(5):889-917. doi: 10.2165/00003495-199244050-00011.